China’s focus on first or best-in-class oncology drugs and innovative R&D will help it to secure further licensing deals in ...

Johns Hopkins experts attribute low RSV numbers to population immunity and new vaccines, while warning about a potentially ...

The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable economic sectors.

Once dismissed as a humble lotus seed, makhana, also called as fox nut, has found its place among health enthusiasts. But ...

At the same time, the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) has progressed, and the UK has ...

Ministerial visits the Precision Health Technologies Accelerator (PHTA) to learn more about health and life sciences innovation ...

The new year is two weeks away, and come 2026, several laws will begin to go into effect, or they'll expand, in the state of ...

Licensing partner Zydus brings extensive commercial experience, marketing more than 225 FDA-approved medicines, providing a strong foundation for a successful launch of FYB206Strong early partnering ...

The US luxury and exotic car market is projected to grow from $110 billion today to between $180 and $215 billion by 2035. The strongest growth is expected in vehicles priced between $100,000 and $170 ...

Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...

In the past week or so, secondary offerings from biotechs Immunovant Inc. (NASDAQ: IMVT), Kymera Therapeutics Inc. (NASDAQ: ...